Tag: 2026
Amgen and AstraZeneca Present Groundbreaking Oncology Data at ESMO, Demonstrating a 58% Reduction in Risk of Death for Small Cell Lung Cancer
Amgen and AstraZeneca presented practice-changing Phase 3 clinical data at the European Society for Medical Oncology (ESMO) 2026 Congress, demonstrating that frontline maintenance therapy combining Imdelltra...
Next-Generation MAKO 4 Robotic-Assisted Surgery System Officially Launched to Advance Precision in Joint Replacement
In a major development for orthopedic surgical technology, medical device innovators and surgical teams have celebrated the official rollout of the MAKO 4, the next-generation robotic-assisted surgical...
Indian Pharmacopoeia Commission Issues Drug Safety Alert Linking Levetiracetam and Topical Decongestants to Specific Adverse Reactions
The Indian Pharmacopoeia Commission (IPC), functioning as the National Coordination Centre for the Pharmacovigilance Programme of India (NCC-PvPI) under the Ministry of Health &...
Rising Yields Hit Sun Pharma’s Fundraising Drive as Bond Issue Misses ₹10,000 Crore Goal
India’s largest drugmaker by market capitalisation Sun Pharmaceutical Industries has raised ₹7,816 crore (~8000 cr) against its ₹10,000-crore fundraising target, highlighting the growing pressure on corporate borrowers as Indian...
GLP-1 Boom: China, India and Brazil Could Unlock a $22 Billion Market by 2035 , J.P. Morgan Estimates
The market for GLP-1 medicines across China, India and Brazil could surge from $6.6 billion currently to $22 billion by 2035, expanding at an estimated annual...
Domestic Manufacturing Breakthroughs Drive Drastic Price Reductions for Rare Disease Therapies in India
Under the National Policy for Rare Diseases (NPRD), the Government of India provides one-time financial assistance of up to ₹50 lakh per patient across...